V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
Biopharma & Life Sciences

NRC Health Executive Compensation (FY25)

NRC · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Trent Green
Median of the other named officers
$1,546,975
6 officers, excluding the chief executive
Latest say-on-pay support
=
June 23, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in Biopharma & Life Sciences, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on NRC Health

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): June 29, 2026
15 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
NRC Health brief$1,500Get the executive brief
Velarion Member, one year
213 figures on this page: 202 cited to the filing that reported them, 11 calculated from figures it prints. See the citations

More on NRC Health

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Michael Hays → Trent Green
CEO pay ratio: 2.2:1 → 137:1

Frequently asked questions

Answers drawn from the data on this page.
Who is NRC Health's chief executive and what were they paid?
Trent Green, Chief Executive Officer, received $11,961,900 in total compensation for fiscal 2025.
What was NRC Health's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 85.3% of votes cast including abstentions in favor at the meeting held June 23, 2026.
What is NRC Health's chief executive pay ratio?
The company reported a chief executive pay ratio of 137:1 for fiscal 2025, against median employee compensation of $87,276.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jona Raasch
Chief Operating Officer
◇——◇——◇◇
Kevin Karas
Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary
◇——◇——◇◇
Helen Hrdy
Chief Growth Officer
◇——◇——◇◇
Michael Hays
Chief Executive Officer and President
◇——◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Karas
Former Senior Vice President-Finance, Chief Financial Officer, Treasurer, and Secretary
Departed during or after this year
◇——◇——◇◇
Helen Hrdy
Chief Customer Officer
◇——◇——◇◇
Jona Raasch
Former Chief Operating Officer
Departed during or after this year
◇——◇——◇◇
Michael Hays
Chief Executive Officer and President
◇——◇——◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Christophe Louvion
Former Chief Product Technology Officer
Departed during or after this year
◇◇—◇——◇◇
Helen Hrdy
Chief Operating Officer
◇◇—◇——◇◇
Jason Hahn
Former Chief Revenue Officer
Departed during or after this year
◇——◇——◇◇
Kevin Karas
Former Senior Vice President-Finance, Chief Financial Officer, Treasurer, and Secretary
Departed during or after this year
◇—————◇◇
Linda Stacy
Former Principal Financial Officer, Principal Accounting Officer, and Secretary and Current Principal Financial Officer
Departed during or after this year
◇—————◇◇
Michael Hays
Chief Executive Officer, President
◇——◇——◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Trent Green
Chief Executive Officer
◇◇◇———◇◇
Shane Harrison
Chief Financial Officer
◇◇◇———◇◇
Helen Hrdy
EVP & Chief Operating Officer
◇◇◇———◇◇
Andy Monnich
EVP & Chief Corporate Development Officer
◇◇◇———◇◇
Jason Rau
Executive Vice President, Sales
◇———◇—◇◇
Michael Hays
Chair; Former Chief Executive Officer, President
Departed during or after this year
◇——◇——◇◇
Linda Stacy
Former Interim Principal Financial Officer
Departed during or after this year
Served on an interim basis
◇—————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Andy MonnichRSU◇——◇——◇
Helen L. HrdyRSU◇——◇——◇
Shane HarrisonRSU◇——◇——◇
Trent GreenRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Trent GreenRSU◇◇——
Shane HarrisonRSU◇◇——
Helen HrdyRSU◇◇——
Option◇—◇1/5/2031
Option◇—◇1/4/2032
Option◇—◇1/4/2033
Andy MonnichRSU◇◇——
Michael HaysOption◇—◇1/4/2033
Option◇—◇1/10/2035
Option◇—◇1/4/2032
Option◇—◇1/5/2031
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Andy Monnich
EVP & Chief Corporate Development Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance base◇
Change-in-control multiple◇
Change-in-control base◇
Equity acceleration on change in control◇
Helen Hrdy
EVP & Chief Operating Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance base◇
Change-in-control multiple◇
Change-in-control base◇
Non-compete period◇
Non-solicit period◇
Linda Stacy
Former Interim Principal Financial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Change-in-control trigger◇
Equity acceleration on change in control◇
Michael Hays
Chair; Former Chief Executive Officer, President · Terms as described in the company’s compensation discussion · citing a 2026 filing
Change-in-control trigger◇
Equity acceleration on change in control◇
Non-compete period◇
Non-solicit period◇
Shane Harrison
Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance base◇
Severance cash amount◇
Change-in-control multiple◇
Change-in-control base◇
Trent Green
Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance base◇
Change-in-control multiple◇
Change-in-control base◇
Equity acceleration on change in control◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John N. Nunnelly
Lead independent director
◇—◇———◇
Penny A. Wheeler
◇—◇———◇
Donald M. Berwick
◇—◇———◇
Parul Bhandari
◇—◇———◇
Stephen H. Lockhart
◇—◇———◇
Trent Green and Michael D. Hays served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Lead independent director premium◇
Equity is delivered as Options.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 23, 2026=◇◇◇
2024May 7, 2025=◇◇◇
2023May 8, 2024=◇◇◇
2022May 11, 2023=◇◇◇
2021May 18, 2022=◇◇◇
2020June 29, 2021=◇◇◇
2019May 21, 2020=◇◇◇
2018May 29, 2019=◇◇◇
2017May 30, 2018=◇◇◇
2016May 9, 2017=◇◇◇
2015May 11, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Trent Green (Chief Executive Officer), FY2025 total compensation $11,961,900 (base salary $697,115) [exec_comp, SEC accession 0001437749-26-015775, filed 2026-05-08]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when NRC Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact NRC Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether NRC Health's disclosed peer group is defensible, who names NRC Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
213 figures on this page: 202 cited to the filing that reported them, 11 calculated from figures it prints.
202 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001437749-26-021938
  2. 0001437749-26-015775
    2025 Director Compensation · 2025 Summary Compensation Table · Compensation Discussion and Analysis · Grants of Plan-Based Awards
  3. 0001437749-25-015965
    Proposal 4 – Approval of the National Research Corporation 2025 Omnibus Incentive Plan.” The text of the 2025 Omnibus Incentive Plan is set forth as Appendix A to the Proxy Statement.
  4. 0001437749-25-011693
    2024 Summary Compensation Table
  5. 0001437749-24-016208
  6. 0001437749-24-011731
    2023 SUMMARY COMPENSATION TABLE
  7. 0001437749-23-014369
  8. 0001437749-23-009608
    2022 SUMMARY COMPENSATION TABLE
  9. 0001437749-22-013292
  10. 0001437749-21-016301
  11. 0001437749-20-011616
  12. 0001437749-19-011113
  13. 0001437749-18-011058
  14. 0001437749-17-008962
  15. 0001437749-16-031944
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “NRC Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/NRC (accessed 2026).
Short form: data: Velarion

The paid brief for NRC Health

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about NRC Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Biopharma & Life Sciences rankings

Chief executive pay — Biopharma & Life SciencesCEO pay ratio — Biopharma & Life SciencesSay-on-pay support — Biopharma & Life Sciences

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy